Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $43,680,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 7,000,000 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the completion of the transaction, the insider owned 252,899 shares in the company, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Up 2.2%

Shares of AVAH traded up $0.15 during mid-day trading on Friday, reaching $6.78. The company’s stock had a trading volume of 510,328 shares, compared to its average volume of 1,345,372. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.73 and a 12-month high of $10.32. The stock has a market cap of $1.48 billion, a PE ratio of 5.74, a price-to-earnings-growth ratio of 0.76 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The company’s 50 day moving average is $6.79 and its 200 day moving average is $7.73.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The firm had revenue of $647.92 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.Aveanna Healthcare’s revenue for the quarter was up 15.9% on a year-over-year basis. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday. Truist Financial upped their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research report on Wednesday, May 20th. BMO Capital Markets decreased their target price on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price for the company in a research report on Friday, March 20th. Finally, Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $10.50.

Hedge Funds Weigh In On Aveanna Healthcare

Several hedge funds have recently bought and sold shares of AVAH. Dynamic Technology Lab Private Ltd lifted its stake in shares of Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after purchasing an additional 1,151 shares in the last quarter. Barclays PLC lifted its stake in shares of Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after purchasing an additional 1,366 shares in the last quarter. Franklin Resources Inc. lifted its stake in shares of Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after purchasing an additional 1,528 shares in the last quarter. Intech Investment Management LLC lifted its stake in shares of Aveanna Healthcare by 9.8% during the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after purchasing an additional 1,739 shares in the last quarter. Finally, Balboa Wealth Partners lifted its stake in shares of Aveanna Healthcare by 13.5% during the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock worth $138,000 after purchasing an additional 2,007 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.